Neurotech International (ASX:NTI) EBIT per Share : A$-0.01 (TTM As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Neurotech International EBIT per Share?

Neurotech International's EBIT per Share for the six months ended in Dec. 2023 was A$-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.01.

During the past 3 years, the average EBIT per Share Growth Rate was -11.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 23.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Neurotech International's EBIT per Share or its related term are showing as below:

ASX:NTI' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -11.2 Med: 30.45 Max: 44.2
Current: -11.2

During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Neurotech International was 44.20% per year. The lowest was -11.20% per year. And the median was 30.45% per year.

ASX:NTI's 3-Year EBIT Growth Rate is ranked worse than
69.93% of 725 companies
in the Medical Devices & Instruments industry
Industry Median: 5.7 vs ASX:NTI: -11.20

Neurotech International's EBIT for the six months ended in Dec. 2023 was A$-3.94 Mil.

Neurotech International EBIT per Share Historical Data

The historical data trend for Neurotech International's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurotech International EBIT per Share Chart

Neurotech International Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EBIT per Share

Get a 7-Day Free Trial

-0.04

-0.01

-0.02

-0.01

Neurotech International Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial										-	-	-0.01	-0.01	-

Neurotech International EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Neurotech International's EBIT per Share for the fiscal year that ended in Jun. 2023 is calculated as

	EBIT per Share		(A: Jun. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-9.049	/	798.772
=	-0.01

Neurotech International's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.938	/	876.821
=	-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01

Neurotech International (ASX:NTI) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Neurotech International EBIT per Share Related Terms

Thank you for viewing the detailed overview of Neurotech International's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurotech International (ASX:NTI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neurotech International Ltd (ASX:NTI) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009

Website

https://www.neurotechinternational.com

Neurotech International Ltd is a medical device and solutions company. It researches, designs, markets, and produces wearable neurotechnology devices to assist with neurological conditions such as autism. Geographically, all the business activities of the firm function through the region of Australia. It operates in one segment named Medical Device Development and Distribution.

Neurotech International (ASX:NTI) Headlines

From GuruFocus

By Dividend Dividend • 06-25-2013

20 Stocks with Yields over 10% and Highest Buy Ratings

By Dividend Dividend • 01-17-2013

13 Stocks With Dividend Yields Over 10%

By Dividend Dividend • 11-12-2014

9 Stocks With Yields Over 10% And Buy Or Better Rating

By Dividend Dividend • 08-17-2013

9 Stocks with Double-Digit Yields and Buy or Better Recommendations

By Dividend Dividend • 07-17-2013

How to Capitalize on the Bakken Oil Boom

By Vitaliy Katsenelson Vitaliy Katsenelson • 11-09-2013

18 Stocks with Very High Yields (More Than 10%) and Earnings Growth

By Dividend Dividend • 12-20-2012